Metabotropic Glutamate Receptor-Mediated Neuromodulation in Sound Localization Circuits

声音定位回路中代谢型谷氨酸受体介导的神经调节

基本信息

  • 批准号:
    9764341
  • 负责人:
  • 金额:
    $ 32.44万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2017
  • 资助国家:
    美国
  • 起止时间:
    2017-09-19 至 2022-08-31
  • 项目状态:
    已结题

项目摘要

Project Summary Neuromodulation mediated by metabotropic glutamate receptors (mGluRs) regulates many brain functions. Dysfunction of mGluR modulation is associated with multiple brain disorders, and drugs targeting mGluRs have been developed for their treatment. However, the functions of mGluRs in the auditory system are poorly understood. In the absence of such knowledge, an understanding of the mechanisms underlying auditory processing and the potential to develop clinically useful strategies targeting mGluRs to prevent or treat hearing disorders will remain limited. The objective in this application is to determine the roles of mGluRs in the auditory brainstem circuit that analyze interaural time differences (ITD) for sound localization. Formulated based upon the previous work and strong preliminary data produced in the applicant's laboratory, the central hypotheses are that 1) mGluRs improve auditory processing by modulating synaptic and intrinsic neuronal properties; 2) hearing deprivation results in plasticity of mGluR modulation; and 3) dysfunctional mGluR modulation leads to compromised auditory processing. These hypotheses will be tested in both avian and mammalian models, utilizing the advantages of each animal model that are not prominent in the other. Furthermore, we will take advantage of a mouse model of fragile X syndrome (FXS), an inherited neurodevelopmental disorder in which exaggerated activity of mGluRs is the core underlying mechanism, to test the hypothesis that dysfunctional mGluR modulation contributes to compromised auditory processing. In vitro physiology (whole-cell and perforated patch recording and sharp electrode recording in brain slices), optical imaging (voltage-sensitive dye and Ca2+ imaging) combined with pharmacological tools, and immunohistochemistry will be used to determine the roles of mGluR modulation in the ITD circuit in normal hearing and hearing-deprived chicks, and in normal hearing and FXS mice. The successful completion of the proposed research will provide in-depth understanding of the roles of mGluRs in sound localization circuits, and may inform the identification of molecular targets for therapeutic intervention in hearing disorders.
项目摘要 由代谢型谷氨酸受体(mGluRs)介导的神经调节调节许多脑功能。 mGluR调节功能障碍与多种脑部疾病相关,靶向mGluR的药物 都是为了治疗而研发的然而,mGluRs在听觉系统中的功能较差, 明白在缺乏这些知识的情况下,理解听觉系统的机制, 加工和潜在的开发临床有用的策略靶向mGluRs,以预防或治疗听力 疾病将保持有限。本申请的目的是确定mGluR在细胞凋亡中的作用。 听觉脑干电路,其分析用于声音定位的耳间时间差(ITD)。制定 根据先前的工作和申请人实验室产生的强有力的初步数据, 假设是:1)mGluRs通过调节突触和内在神经元来改善听觉加工 性质; 2)听力剥夺导致mGluR调节的可塑性;以及3)功能失调的mGluR 调制导致受损的听觉处理。这些假设将在鸟类和 哺乳动物模型,利用每种动物模型的优点,而这些优点在另一种动物模型中并不突出。 此外,我们将利用脆性X综合征(FXS)的小鼠模型, 神经发育障碍,其中mGluRs的过度活性是核心潜在机制, 测试功能失调的mGluR调制有助于受损的听觉处理的假设。在 体外生理学(全细胞和穿孔贴片记录以及脑切片中的尖电极记录), 光学成像(电压敏感染料和Ca 2+成像)结合药理学工具,以及 免疫组织化学将用于确定正常人ITD回路中mGluR调节的作用。 听力和听力剥夺的小鸡,以及正常听力和FXS小鼠。圆满完成 拟议的研究将提供对mGluRs在声音定位回路中的作用的深入理解, 并且可以为听力障碍的治疗干预提供分子靶点的鉴定。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Yong Lu其他文献

Yong Lu的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Yong Lu', 18)}}的其他基金

Induction of autosis to overcome resistance in adoptive cell therapy for solid tumors
诱导自体死亡以克服实体瘤过继细胞治疗中的耐药性
  • 批准号:
    10629835
  • 财政年份:
    2023
  • 资助金额:
    $ 32.44万
  • 项目类别:
Intrapleural immunotherapeutic nanoparticles for MPE treatment
用于 MPE 治疗的胸膜内免疫治疗纳米粒子
  • 批准号:
    10673709
  • 财政年份:
    2021
  • 资助金额:
    $ 32.44万
  • 项目类别:
Intrapleural immunotherapeutic nanoparticles for MPE treatment
用于 MPE 治疗的胸膜内免疫治疗纳米粒子
  • 批准号:
    10456907
  • 财政年份:
    2021
  • 资助金额:
    $ 32.44万
  • 项目类别:
The Unique Roles of Tumor-Specific Th9 Cells for Solid Tumor Eradication
肿瘤特异性 Th9 细胞在实体瘤根除中的独特作用
  • 批准号:
    10177223
  • 财政年份:
    2021
  • 资助金额:
    $ 32.44万
  • 项目类别:
The Unique Roles of Tumor-Specific Th9 Cells for Solid Tumor Eradication
肿瘤特异性 Th9 细胞在实体瘤根除中的独特作用
  • 批准号:
    10557757
  • 财政年份:
    2021
  • 资助金额:
    $ 32.44万
  • 项目类别:
The Unique Roles of Tumor-Specific Th9 Cells for Solid Tumor Eradication
肿瘤特异性 Th9 细胞在实体瘤根除中的独特作用
  • 批准号:
    10706513
  • 财政年份:
    2021
  • 资助金额:
    $ 32.44万
  • 项目类别:
Eradication of Escaped Variant Tumor Cells for Cancer Immunotherapy
根除逃逸变异肿瘤细胞以进行癌症免疫治疗
  • 批准号:
    10541139
  • 财政年份:
    2021
  • 资助金额:
    $ 32.44万
  • 项目类别:
Intrapleural immunotherapeutic nanoparticles for MPE treatment
用于 MPE 治疗的胸膜内免疫治疗纳米粒子
  • 批准号:
    10296779
  • 财政年份:
    2021
  • 资助金额:
    $ 32.44万
  • 项目类别:
Eradication of Escaped Variant Tumor Cells for Cancer Immunotherapy
根除逃逸变异肿瘤细胞以进行癌症免疫治疗
  • 批准号:
    10557758
  • 财政年份:
    2021
  • 资助金额:
    $ 32.44万
  • 项目类别:
P38 MAPK is a molecular switch that controls the acquired resistance in adoptive cell therapy
P38 MAPK 是一种分子开关,可控制过继性细胞疗法中的获得性耐药
  • 批准号:
    10028420
  • 财政年份:
    2020
  • 资助金额:
    $ 32.44万
  • 项目类别:

相似海外基金

Quantification of Neurovasculature Changes in a Post-Hemorrhagic Stroke Animal-Model
出血性中风后动物模型中神经血管变化的量化
  • 批准号:
    495434
  • 财政年份:
    2023
  • 资助金额:
    $ 32.44万
  • 项目类别:
Small animal model for evaluating the impacts of cleft lip repairing scar on craniofacial growth and development
评价唇裂修复疤痕对颅面生长发育影响的小动物模型
  • 批准号:
    10642519
  • 财政年份:
    2023
  • 资助金额:
    $ 32.44万
  • 项目类别:
Bioactive Injectable Cell Scaffold for Meniscus Injury Repair in a Large Animal Model
用于大型动物模型半月板损伤修复的生物活性可注射细胞支架
  • 批准号:
    10586596
  • 财政年份:
    2023
  • 资助金额:
    $ 32.44万
  • 项目类别:
A Comparison of Treatment Strategies for Recovery of Swallow and Swallow-Respiratory Coupling Following a Prolonged Liquid Diet in a Young Animal Model
幼年动物模型中长期流质饮食后吞咽恢复和吞咽呼吸耦合治疗策略的比较
  • 批准号:
    10590479
  • 财政年份:
    2023
  • 资助金额:
    $ 32.44万
  • 项目类别:
Diurnal grass rats as a novel animal model of seasonal affective disorder
昼夜草鼠作为季节性情感障碍的新型动物模型
  • 批准号:
    23K06011
  • 财政年份:
    2023
  • 资助金额:
    $ 32.44万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Longitudinal Ocular Changes in Naturally Occurring Glaucoma Animal Model
自然发生的青光眼动物模型的纵向眼部变化
  • 批准号:
    10682117
  • 财政年份:
    2023
  • 资助金额:
    $ 32.44万
  • 项目类别:
A whole animal model for investigation of ingested nanoplastic mixtures and effects on genomic integrity and health
用于研究摄入的纳米塑料混合物及其对基因组完整性和健康影响的整体动物模型
  • 批准号:
    10708517
  • 财政年份:
    2023
  • 资助金额:
    $ 32.44万
  • 项目类别:
A Novel Large Animal Model for Studying the Developmental Potential and Function of LGR5 Stem Cells in Vivo and in Vitro
用于研究 LGR5 干细胞体内外发育潜力和功能的新型大型动物模型
  • 批准号:
    10575566
  • 财政年份:
    2023
  • 资助金额:
    $ 32.44万
  • 项目类别:
Elucidating the pathogenesis of a novel animal model mimicking chronic entrapment neuropathy
阐明模拟慢性卡压性神经病的新型动物模型的发病机制
  • 批准号:
    23K15696
  • 财政年份:
    2023
  • 资助金额:
    $ 32.44万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
The effect of anti-oxidant on swallowing function in an animal model of dysphagia
抗氧化剂对吞咽困难动物模型吞咽功能的影响
  • 批准号:
    23K15867
  • 财政年份:
    2023
  • 资助金额:
    $ 32.44万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了